AstraZeneca PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other
pharmaceutical manufacturers in Europe:
Novo Nordisk As
of DENMARK
(2019
sales of 122.02 billion Danish Kroner [US$19.20 billion]
of which 84%
was Diabetes and obesity),
Merck KGaA
of GERMANY
(16.15 billion Euros [US$18.91 billion]
of which 42%
was Life Science), and
Lonza Group AG
which is
based in SWITZERLAND
(5.92 billion Swiss Francs [US$6.44 billion]
of which 70%
was Pharma&Biotech).
Sales Analysis.
During the year ended December of 2019, sales at
AstraZeneca PLC were £19.06 billion (US$24.28 billion).
This
is
an
increase of 14.8%
versus 2018, when the company's sales were £16.60 billion.